No Detail Found!

Prothrombin G20210a Gene Mutation in Pregnant Females with Thrombotic Obstetric Complications.

Author(s)
Maha Anis Alam Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Mohammad Ayyub Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan; Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Saqib Qayyum Ahmad Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Nosheen Ali Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine the frequency of prothrombin G20210A gene mutation in pregnant females with adverse thrombotic obstetric complication and to compare it with prothrombin G20210A gene's frequency in control population. Study Design: Case control study. Place and Duration of Study: Department of Haematology, Army Medical College Rawalpindi and Military Hospital Rawalpindi, from Nov 2013 to Oct 2014. Material and Methods: Sixty pregnant females were included in the study; 30 were cases with adverse thrombotic obstetric complication, while 30 were controls. Detailed history was obtained and 3 ml blood in EDTA tube was collected. DNA was extracted from whole blood and through RT-PCR, presence of prothrombin G20210A gene mutation was looked for in patients and controls. Data was analyzed using SPSS 21. Results: A total of 60 women-30 cases with thrombotic obstetric complications as 'cases' and 30 as 'controls'- were included in the study. Mean age of 'cases' was 28.70 ± 4.23 years while that of 'controls' was 27.33 ± 4.49 years. There was no statistically significant difference among the two groups (p=0.54). In case group only one of 30 (3.3%) patients had heterozygous F2 G20210A mutation while 29 (96.7%) patients had wild type allele. In control group, all the 30 (100%) subjects had wild type allele. The odds of finding the mutation in cases was 1:29 i.e. 0.03 as compared to zero in the control group. The difference was statistically insignificant (p= 0.5). Conclusion: Our study shows that the frequency of F2 G20210A gene mutation in pregnant females having adverse thrombotic obstetric complications was not significantly different from its frequency in control population.
Publication Details
Page(s) 13-17
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 1, Year: 2018

Request the full text from PASTIC

References
BaglinT.,HoffbrandAV,CatoskyD,TuddenhamEGD,GreenAR, 2011.Heritable thrombophilia,Wiley Blackwell, Oxford UK 872 -87
GomezK,TuddenhamEGD,McVeyJH,HoffbrandAV,CatoskyD,TuddenhamEGD,GreenAR, 2011.Normal haemostasis,Wiley Blackwell, Oxford UK 746 -71
GiovanniL,AntonioAP,DaniloC,StefanoG,ThereseD,ElisabettaRM, 2007.Thrombophilias and pregnancy complications: A case control study,IJBS 3 168 -75
NaeemMA,AnwarM,AliW,AyyubM., 2006.Prevalence of prothrombin gene mutation in general population: A pilot study,Clin Appl Thromb Hemost 12 223 -6
PrestonFE,RosendaalFR,WalkerID,BrietE,BerntorpE,ConardJ, 1996.Increased fetal loss in women with heritable thrombophilia,Lancet 348 913 -6
KupfermincMJ,EldorA,SteinmanN,ManyA,Bar-AmA,JaffaA, 1999.Increased frequency of genetic thrombophilia in women with complications of pregnancy,N Engl J Med 340 9 -13
GrandoneE,MargaglioneM,ColaizzoD,CappucciG,SciannaméN,MontanaroS, 1999.Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria,Thromb Haemost 81 349 -52
GerhardtA,ScharfRE,BeckmannMW,StruveS,BenderHG,PillnyM, 2000.Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium,N Engl J Med 342 374 -80
KupfermincMJ,PeriH,ZwangE,YaronY,WolmanI,EldorA, 2000.High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruption placentae and second trimester loss,Acta Obstet Gynecol Scand 79 963 -7
MartinelliI,TaioliE,CetinI,MarinoniA,GerosaS,VillaMV, 2000.Mutations in coagulation factors in women with unexplained late fetal loss,N Engl J Med 343 1015 -8
FokaZJ,LambropoulosAF,SaravelosH,KarasGB,KaravidaA,AgorastosT, 2000.Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages,Hum Reprod 15 458 -62
Reznikoff-EtievanMF,CayolV,CarbonneB,RobertA,CouletF,MillezJ, 2001.Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage,BJOG 108 1251 -4
AlfirevicZ,RobertsD,MartlewV, 2002.How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review,Eur J Obstet Gynecol Reprod Biol 101 6 -14
KuttehWH,TriplettDA, 2006.Thrombophilias and recurrent pregnancy loss,Semin Reprod Med 24 54 -66
Infante-RivardC,RivardGE,YotovWV,GéninE,GuiguetM,WeinbergC, 2002.Absence of association of thrombophilia polymorphisms with intrauterine growth restriction,N Engl J Med 347 19 -25
NathCA,AnanthCV,DeMarcoC,Vintzileos AM, 2008.Low birth-weight in relation to placental abruption and maternal thrombophilia status,Am J Obstet Gynecol 198 293e1 -5
LinJ,AugustP, 2005.Genetic thrombophilias and preeclampsia: A meta-analysis,Obstet Gynecol 105 182 -92
ZahedLF,RayesRF,MahfouzRA,TaherAT,MaaroufHH,NassarAH, 2006.Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon,Am J Obstet Gynecol 195 1114 -8
SilverRM,ZhaoY,SpongCY,SibaiB,Wendel-JrG,WenstromK, 2010.Prothrombin gene G20210A mutation and obstetric complications,Obstet Gynecol 115 14 -20
0

Citations

0

Downloads

75

Views